Johns Hopkins Medicine Office of Continuing Medical Education
Skip Navigation.
How ToAbout CMECME CalendarOnline/EnduringProgramsResources & DownloadsContact & Travel InformationBlog
CME Online
Forgot your password?

Not Registered yet?

Create a new account.

80021039: What's New in Diabetic Retinopathy and Venous Occlusive Disease

November 20, 2009
  • Download Brochure
  • Send to Colleague
  • Back to List
Click here for a text version of the brochure
Text version of brochure


What's New in Diabetic Retinopathy and Venous Occlusive Disease Brochure Cover Image


ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 7.0 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
















Description:
Approximately 4.0 million Americans age 40 and older have diabetic retinopathy, including almost 1.0 million who have vision-threatening disease, such as macular edema. Diabetic retinopathy and related diseases such as retinal vein occlusions remain leading and growing causes of blindness in adults who make up the work force. Despite this, diabetic retinopathy and venous occlusive disease are often under-diagnosed and under-treated. This annual activity highlights new information being reported by the Diabetic Retinopathy Clinical Research Network and others that impacts current standard care and management strategies.

Objectives:
After attending this activity, the participant will demonstrate the ability to:
1. Summarize evidence of relation of diabetic control to incidence and severity of retinopathy
2. Determine which patients are appropriate for laser treatment
3. Diagnose diabetic macular edema, severe non-proliferative retinopathy, and high risk proliferative diabetic retinopathy
4. Be familiar with new experimental treatment options

Talks

November 20, 2009  7:55 AM to 8:00 AM

Welcome and Introduction

Mcdonnell, Peter
November 20, 2009  8:00 AM to 8:05 AM

Conference Goals

Solomon, Sharon
November 20, 2009  8:05 AM to 8:25 AM

From the ETDRS to the DRCR.net: Laser Photocoagulation and Diabetic Macular Edema

Solomon, Sharon
To present past and current clinical trials data supporting the role of focal laser in treatment of diabetic macular edema.
November 20, 2009  8:25 AM to 8:45 AM

Management of Persistent DME after Laser

Bressler, Neil
To understand the current role of treatments other than laser in the management of persistent DME after laser.
November 20, 2009  8:45 AM to 9:05 AM

What is the Role of Anti-VEGF Agents for Diabetic Macular Edema?

Nguyen, Quan Dong
To describe the various selected VEGF antagonists that are currently being evaluated as therapeutic options for diabetic macular edema.
November 20, 2009  9:05 AM to 9:25 AM

Is There a Role for Vitrectomy for Diabetic Macular Edema?

Scott, Adrienne
To evaluate the role for virectomy in diabetic macular edema.
November 20, 2009  10:05 AM to 11:05 AM

Putting It All Together: Managing Diabetic Macular Edema Cases in 2009

Bressler, Neil
To determine which patients with DME are appropriate for laser treatment and understand the management of DME.
November 20, 2009  11:05 AM to 11:25 AM

The Metabolic Syndrome and the Prevention of Diabetes

Margolis, Simeon
To understand the factors that determine the metabolic syndrome. To appreciate the relationships between metabolic syndrome, diabete and cardiovascular disease.
November 20, 2009  11:25 AM to 11:45 AM

Diabetes Medical Management in 2009

Saudek, Christopher
November 20, 2009  11:45 AM to 12:00 PM

Ophthalmologists’ Understanding of the Diabetes Control and Complications Trial (DCCT)

Bressler, Susan
To understand the design and trial and major results of DCCT.
November 20, 2009  12:00 PM to 12:15 PM

Lessons Learned From Peribulbar Steroid Injections for Diabetic Macular Edema and Other Issues from DRCR Network

Chew, Emily
To understand the complications of peribulbar injections for diabetic macular edema and the need for two years of follow-up for complications assessment.
November 20, 2009  1:15 PM to 1:35 PM

PRP: New Knowledge on a Time-Honored Approach

Zimmer-Galler, Ingrid
To review the incidence and extent of macular edema following panretinal photocoagulation whether performed in one or multiple sessions.
November 20, 2009  1:35 PM to 1:55 PM

Is There a Role for Anti-VEGF Drugs in Proliferative Diabetic Retinopathy?

Do, Diana
November 20, 2009  1:55 PM to 2:15 PM

Vitrectomy for Proliferative Diabetic Retinopathy

Gehlbach, Peter
To discuss current indications for vitrectomy to treat proliferative diabetic retinopathy.
November 20, 2009  2:15 PM to 2:30 PM

Why Isn’t a Medical Work-up Indicated for Venous Occlusive Disease?

Ying, Howard
To determine which patients merit a medical work-up.
November 20, 2009  2:30 PM to 2:45 PM

Laser Management of Venous Occlusive Disease

Finkelstein, Daniel
To appropriately recommend laser management for both branch and central vein occlusion.
November 20, 2009  3:15 PM to 3:35 PM

Anti-VEGF Drugs for Venous Occlusive Disease

Campochiaro, Peter
To determine when anti-VEGF drugs might be useful for patients with vein occlusions.
November 20, 2009  3:35 PM to 3:55 PM

Steroids (SCORE Study)

Sung, Jennifer
To understand the results of the score study with regards to corticosteroid administration in vein occlusions.
November 20, 2009  3:55 PM to 4:15 PM

Intravitreal Injection Techniques

Wiley, Henry
To identify the risks of intravitreal injection. To demonstrate knowledge of evidence-based recommendations to maximize the safety of injection.
November 20, 2009  4:15 PM to 4:55 PM

Case Presentations

Sung, Jennifer
November 20, 2009  4:55 PM to 5:00 PM

Closing Remarks

Solomon, Sharon

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

Event Information
Johns Hopkins School of Medicine, Turner Auditorium
720 Rutland Ave
Baltimore, MD
Directions

Target Audience(s)

Ophthalmologists, Retina Specialists, Residents, Fellows and Eye Care Professionals

Course Director

Neil Bressler

Course Co-Director

Sharon Solomon

Hotel Website

www.renaissancehotels.com/BWISH, reserve a room and use course code JOHJOHA or call the hotel directly. 410-5471200

Contact Info

General Info: 410.502.9634

Mailing Address:
Johns Hopkins University School
of Medicine
Thomas B. Turner Building
720 Rutland Avenue, Room 20
Baltimore, Maryland 21205-2195

Email Us

© 2010 Johns Hopkins University
School of Medicine | Office of Continuing Medical Education
Home | Privacy Policy | Sitemap
Managed Hosting by PEER 1
HTML to PDF conversion by ABCpdf.NET